FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311194926> ?p ?o ?g. }

• W4311194926 endingPage "PR001" @default.
• W4311194926 startingPage "PR001" @default.
• W4311194926 abstract "Abstract Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein with a wide range of functions including ribosome biogenesis, mRNA processing, and maintenance of genomic stability. In acute myeloid leukemia (AML), the terminal exon of NPM1 is often mutated (~30% of adult AMLs), changing the nucleolar localization signal into a nuclear export signal, which results in a shift of the protein to the cytoplasm (NPM1c). AMLs carrying this mutation have an aberrant expression of the HOXA genes, whose overexpression leads to leukemogenic transformation. The gene regulatory role of NPM1c has long been an enigma. Recently, it was shown that depletion or re-localization of the NPM1c protein into the nucleus [PG1] causes downregulation of the HOXA genes, leading to the speculation that NPM1c modulates transcription of HOXA genes. Here, we found NPM1c binds to chromatin and is located genome-wide at gene promoters and colocalized at active regions marked by H3K27ac in NPM1c leukemia cell lines and primary leukemia blasts. NPM1c clearly binds to known leukemia-driving genes - posterior HOXA, HOXB, and MEIS1/PBX3 genes as well as novel targets -IRX5 and NKX2-3. After PROTAC degradation of NPM1c, we observed a significant RNA polymerase II elongation defect genome-wide. The dramatic elongation defect is caused by the loss of the Super Elongation Complex (SEC) chromatin binding. Further tests suggest that loss of NPM1c leads to disruption of RNA polymerase II condensates as well as other direct transcriptional regulators of HOX genes - Menin and AFF4 through IDR interactions. We found that pulse PROTAC degradation of NPM1c leads to sustained differentiation with the loss of histone acetylation at NPM1c target loci. Further, NPM1c maintains the active chromatin state of target genes by antagonizing HDAC activity. Additionally, we found that NPM1c’s activation of the leukemia driving genes depends on the pre-established active chromatin state in the transformed hematopoietic stem and progenitor cells. NPM1c alone is not sufficient to activate these leukemia driving genes with heterochromatin marks accumulated. We also found that NPM1c binds to genomic regions that have been pre-bound by its export partner, XPO1. The XPO1 inhibitors Selinexor and Eltanexor can displace NPM1c from chromatin. The combination of clinical-grade XPO1 inhibitor eltanexor and Menin inhibitor MI-3454 displayed a strong synergy in inducing differentiation and reducing leukemia driving gene expression in the NPM1 mutated leukemia cell lines and PDX model, which promises to be an effective combination therapy for NPM1c leukemia patients. Citation Format: Xue Qing Wang, Dandan Fan, Yiman Liu, Qinyu Han, Jolanta Grembecka, Tomasz Cierpicki, Jianzhong Su, Shasha Chong, Liling Wan, Xiaotian Zhang. Mutant NPM1 hijacks transcriptional hub to maintain pathogenic gene programs and block differentiation in acute myeloid leukemia. [abstract]. In: Proceedings of the AACR Special Conference: Cancer Epigenomics; 2022 Oct 6-8; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2022;82(23 Suppl_2):Abstract nr PR001." @default.
• W4311194926 created "2022-12-24" @default.
• W4311194926 creator A5012926126 @default.
• W4311194926 creator A5018559319 @default.
• W4311194926 creator A5021396313 @default.
• W4311194926 creator A5021557384 @default.
• W4311194926 creator A5046118596 @default.
• W4311194926 creator A5058180819 @default.
• W4311194926 creator A5061702219 @default.
• W4311194926 creator A5077647962 @default.
• W4311194926 creator A5080568394 @default.
• W4311194926 creator A5089868970 @default.
• W4311194926 date "2022-12-01" @default.
• W4311194926 modified "2023-09-24" @default.
• W4311194926 title "Abstract PR001: Mutant NPM1 hijacks transcriptional hub to maintain pathogenic gene programs and block differentiation in acute myeloid leukemia" @default.
• W4311194926 doi "https://doi.org/10.1158/1538-7445.cancepi22-pr001" @default.
• W4311194926 hasPublicationYear "2022" @default.
• W4311194926 type Work @default.
• W4311194926 citedByCount "0" @default.
• W4311194926 crossrefType "journal-article" @default.
• W4311194926 hasAuthorship W4311194926A5012926126 @default.
• W4311194926 hasAuthorship W4311194926A5018559319 @default.
• W4311194926 hasAuthorship W4311194926A5021396313 @default.
• W4311194926 hasAuthorship W4311194926A5021557384 @default.
• W4311194926 hasAuthorship W4311194926A5046118596 @default.
• W4311194926 hasAuthorship W4311194926A5058180819 @default.
• W4311194926 hasAuthorship W4311194926A5061702219 @default.
• W4311194926 hasAuthorship W4311194926A5077647962 @default.
• W4311194926 hasAuthorship W4311194926A5080568394 @default.
• W4311194926 hasAuthorship W4311194926A5089868970 @default.
• W4311194926 hasConcept C101762097 @default.
• W4311194926 hasConcept C104317684 @default.
• W4311194926 hasConcept C111039654 @default.
• W4311194926 hasConcept C150194340 @default.
• W4311194926 hasConcept C153911025 @default.
• W4311194926 hasConcept C167227067 @default.
• W4311194926 hasConcept C2778729363 @default.
• W4311194926 hasConcept C2779419633 @default.
• W4311194926 hasConcept C2908722627 @default.
• W4311194926 hasConcept C502942594 @default.
• W4311194926 hasConcept C54355233 @default.
• W4311194926 hasConcept C54757728 @default.
• W4311194926 hasConcept C64350747 @default.
• W4311194926 hasConcept C67705224 @default.
• W4311194926 hasConcept C83640560 @default.
• W4311194926 hasConcept C86803240 @default.
• W4311194926 hasConcept C88478588 @default.
• W4311194926 hasConcept C95444343 @default.
• W4311194926 hasConceptScore W4311194926C101762097 @default.
• W4311194926 hasConceptScore W4311194926C104317684 @default.
• W4311194926 hasConceptScore W4311194926C111039654 @default.
• W4311194926 hasConceptScore W4311194926C150194340 @default.
• W4311194926 hasConceptScore W4311194926C153911025 @default.
• W4311194926 hasConceptScore W4311194926C167227067 @default.
• W4311194926 hasConceptScore W4311194926C2778729363 @default.
• W4311194926 hasConceptScore W4311194926C2779419633 @default.
• W4311194926 hasConceptScore W4311194926C2908722627 @default.
• W4311194926 hasConceptScore W4311194926C502942594 @default.
• W4311194926 hasConceptScore W4311194926C54355233 @default.
• W4311194926 hasConceptScore W4311194926C54757728 @default.
• W4311194926 hasConceptScore W4311194926C64350747 @default.
• W4311194926 hasConceptScore W4311194926C67705224 @default.
• W4311194926 hasConceptScore W4311194926C83640560 @default.
• W4311194926 hasConceptScore W4311194926C86803240 @default.
• W4311194926 hasConceptScore W4311194926C88478588 @default.
• W4311194926 hasConceptScore W4311194926C95444343 @default.
• W4311194926 hasIssue "23_Supplement_2" @default.
• W4311194926 hasLocation W43111949261 @default.
• W4311194926 hasOpenAccess W4311194926 @default.
• W4311194926 hasPrimaryLocation W43111949261 @default.
• W4311194926 hasRelatedWork W1972303909 @default.
• W4311194926 hasRelatedWork W2013095276 @default.
• W4311194926 hasRelatedWork W2014141207 @default.
• W4311194926 hasRelatedWork W2070743892 @default.
• W4311194926 hasRelatedWork W2099083409 @default.
• W4311194926 hasRelatedWork W2148766680 @default.
• W4311194926 hasRelatedWork W3157271623 @default.
• W4311194926 hasRelatedWork W4281941896 @default.
• W4311194926 hasRelatedWork W4311194926 @default.
• W4311194926 hasRelatedWork W4315479573 @default.
• W4311194926 hasVolume "82" @default.
• W4311194926 isParatext "false" @default.
• W4311194926 isRetracted "false" @default.
• W4311194926 workType "article" @default.